Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis

European Journal of Neuroscience

Volumn 18, Issue 6, 2003, Pages 1527-1534

  Maihöfner, Christian ^a   Probst Cousin, Stefan ^a   Bergmann, Markus ^b   Neuhuber, Winfried ^a   Neundörfer, Bernhard ^a   Heuss, Dieter ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Institute of Clinical Neuropathology   (Germany)

Author keywords

Cyclooxygenase; Motor neuron disease; Prostaglandins

Indexed keywords

BIOLOGICAL MARKER; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN E2;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELLULAR DISTRIBUTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYMOLOGY; FEMALE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNEURON; MALE; MICROGLIA; MOTONEURON; PATHOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SPINAL CORD; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; TISSUE SECTION;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CELL COUNT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; LUMBOSACRAL REGION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEUROGLIA; NEURONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SPINAL CORD;

EID: 0141816705     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02879.x     Document Type: Article

References (41)

1. Almer, G., Guegan, C., Teismann, P., Naini, A., Rosoklija, G., Hays, A.P., Chen, C. & Przedborski, S. (2001) Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol., 49, 176-185.
2. Almer, G., Teismann, P., Stevic, Z., Halaschek-Wiener, J., Deecke, L., Kostic, V. & Przedborski, S. (2002) Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology, 58, 1277-1279.
3. Beiche, F., Scheuerer, S., Brune, K., Geisslinger, G. & Goppelt-Struebe, M. (1996) Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett., 390, 165-169.
4. Brooks, B.R. (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J. Neurol. Sci., 124 (Suppl.), 96-107.
5. Brown, R.H. Jr (1995) Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell, 80, 687-692.
6. Charalambous, M.P., Maihofner, C., Bhambra, U., Lightfoot, T. & Gooderham, N.J. (2003) Upregulation of cyclooxygenase-2 is accompanied by increased expression of nuclear factor-kappa B and I kappa B kinase-alpha in human colorectal cancer epithelial cells. Br. J. Cancer, 88, 1598-1604.
7. Damm, J., Rau, T., Maihofner, C., Pahl, A. & Brune, K. (2001) Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body. Exp. Eye Res., 72, 611-621.
8. Drachman, D.B., Frank, K., Dykes-Hoberg, M., Teismann, P., Almer, G., Przedborski, S. & Rothstein, J.D. (2002) Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol., 52, 771-778.
9. Drachman, D.B. & Rothstein, J.D. (2000) Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann. Neurol., 48, 792-795.
10. Fray, A.E., Ince, P.G., Banner, S.J., Milton, I.D., Usher, P.A., Cookson, M.R. & Shaw, P.J. (1998) The expression of the glial glutamate transporter protein EAAT2 in motor neuron disease: an immunohistochemical study. Eur. J. Neurosci., 10, 2481-2489.
11. Friedlander, R.M., Brown, R.H., Gagliardini, V., Wang, J. & Yuan, J. (1997) Inhibition of ICE slows ALS in mice. Nature, 388, 31.
12. Fukada, K, Nagano, S., Satoh, M., Tohyama, C., Nakanishi, T., Shimizu, A., Yanagihara, T. & Sakoda, S. (2001) Stabilization of mutant Cu/Zn superoxide dismutase (SOD1) protein by coexpressed wild SOD1 protein accelerates the disease progression in familial amyotrophic lateral sclerosis mice. Eur. J. Neurosci., 14, 2032-2036.
13. Ghezzi, P., Bernardini, R., Giuffrida, R., Bellomo, M., Manzoni, C., Comoletti, D., Di Santo, E., Benigni, F. & Mennini, T. (1998) Tumor necrosis factor is increased in the spinal cord of an animal model of motor neuron degeneration. Eur. Cytokine Netw., 9, 139-144.
14. Grilli, M. & Memorandum, M. (1999) Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochem. Pharmacol., 57, 1-7.
15. Harris, R.C., McKanna, J.A., Akai, Y., Jacobson, H.R., DuBois, R.N. & Breyer, M.D. (1994) Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest., 94, 2504-2510.
16. Hawkey, C.J. (1999) COX-2 inhibitors. Lancet, 353, 307-314.
17. Irving, D., Rebeiz, J.J. & Tomlinson, B.E. (1974) The numbers of limb motor neurones in the individual segments of the human lumbosacral spinal cord. J. Neurol. Sci., 21, 203-212.
18. Kawamata, T., Akiyama, H., Yamada, T. & McGeer, P.L. (1992) Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol., 140, 691-707.
19. Kelley, K.A., Ho, L., Winger, D., Freire-Moar, J., Borelli, C.B., Aisen, P.S. & Pasinetti, G.M. (1999) Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am. J. Pathol., 155, 995-1004.
20. Kunz, T. & Oliw, E.H. (2001) The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur. J. Neurosci., 13, 569-575.
21. Li, M., Ona, V.O., Guegan, C., Chen, M., Jackson-Lewis, V., Andrews, L.J., Olszewski, A.J., Stieg, P.E., Lee, J.P., Przedborski, S. & Friedlander, R.M. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science, 288, 335-339.
22. Maihofner, C., Charalambous, M.P., Bhambra, U., Lightfoot, T., Geisslinger, G. & Gooderham, N.J. (2003) Expression of cyclooxygenase-2 parallels expression of interleukin-lbeta, interleukin-6 and NF-kappaB in human colorectal cancer. Carcinogenesis, 24, 665-671.
23. Maihofner, C., Euchenhofer, C., Tegeder, I., Beck, K.F., Pfeilschifter, J. & Geisslinger, G. (2000a) Regulation and immunhistochemical localization of nitric oxide synthases and soluble guanylyl cyclase in mouse spinal cord following nociceptive stimulation. Neurosci. Lett., 290, 71-75.
24. Maihofner, C., Schlotzer-Schrehardt, U., Guhring, H., Zeilhofer, H.U., Naumann, G.O., Pahl, A., Mardin, C., Tamm, E.R. & Brune, K. (2001) Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest. Ophthalmol. Vis. Sci., 42, 2616-2624.
25. Maihofner, C., Tegeder, I., Euchenhofer, C., deWitt, D., Brune, K., Bang, R., Neuhuber, W. & Geisslinger, G. (2000b) Localization and regulation of cyclo-oxygenase-1 and - and neuronal nitric oxide synthase in mouse spinal cord. Neuroscience, 101, 1093-1108.
26. McGeer, P.L. & McGeer, E.G. (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve, 26, 459-470.
27. Mirjany, M., Ho, L. & Pasinetti, G.M. (2002) Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J. Pharmacol. Exp. Ther., 301, 494-500.
28. Pasinetti, G.M. (1998) Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions. J. Neurosci. Res., 54, 1-6.
29. Pasinetti, G.M. & Aisen, P.S. (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience, 87, 319-324.
30. Plaitakis, A., Constantakakis, E. & Smith, J. (1988) The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann. Neurol., 24, 446-449.
31. Pompl, P.N., Ho, L., Bianchi, M., McManus, T., Qin, W. & Pasinetti, G.M. (2003) A therapeutic role for cyclooxygenase-2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. FASEB J., 17, 725-727.
32. Probst-Cousin, S., Kowolik, D., Kuchelmeister, K., Kayser, C., Neundorfer, B. & Heuss, D. (2002) Expression of annexin-1 in multiple sclerosis plaques. Neuropathol. Appl. Neurobiol., 28, 292-300.
33. Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J.P. & Deng, H.X. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 362, 59-62.
34. Rowland, L.P. & Shneider, N.A. (2001) Amyotrophic lateral sclerosis. N. Engl. J. Med., 344, 1688-1700.
35. Scali, C., Prosperi, C., Vannucchi, M.G., Pepeu, G. & Casamenti, F. (2000) Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease. Eur. J. Neurosci., 12, 1900-1912.
36. Sekizawa, T., Openshaw, H., Ohbo, K., Sugamura, K., Itoyama, Y. & Niland, J.C. (1998) Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases. J. Neurol. Sci., 154, 194-199.
37. Stephens, B., Navarrete, R. & Guiloff, R.J. (2001) Ubiquitin immunoreactivity in presumed spinal intemeurones in motor neurone disease. Neuropathol. Appl. Neurobiol., 27, 352-361.
38. Tomlinson, B.E., Irving, D. & Rebeiz, J.J. (1973) Total numbers of limb motor neurones in the human lumbosacral cord and an analysis of the accuracy of various sampling procedures. J. Neurol. Sci., 20, 313-327.
39. Vane, J.R., Bakhle, Y.S. & Botting, R.M. (1998) Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97-120.
40. Yasojima, K., Tourtellotte, W.W., McGeer, E.G. & McGeer, P.L. (2001) Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology, 57, 952-956.
41. Zindy, F., Quelle, D.E., Roussel, M.F. & Sherr, C.J. (1997) Expression of the pl6INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene, 15, 203-211.